Key Takeaways Neogen sees gains from product launches, Animal Safety demand and progress on 3M Food Safety integration.NEOG highlights growth across biologics, wound care, substrates, reagents and insect control products.Neogen faces high debt, macro pressures and expects a $10M annualized impact from steep U.S. tariff rates.Neogen Corporation (NEOG) is well-poised to gain in the coming quarters, thanks to its continued product development efforts that enhance its existing offerings and advance its business ...

Company Developments - Neogen Corporation (NEOG) has entered into a strategic licensing and supply agreement with Syngenta, granting exclusive rights to market and sell Talon-G and Talon Weatherblok XT rodenticides in the United States and Canada, which is expected to enhance Neogen's rodenticide portfolio with established products [1][5] - Following the announcement, NEOG shares increased by 4.7% to $6.70 in after-market trading [2] - Neogen's market capitalization stands at $1.43 billion, with an earnings yield of 5.75%, significantly higher than the industry's 0.04% [4] - The Zacks Consensus Estimate for fiscal 2026 earnings is projected at 44 cents per share, indicating a growth of 17.1% from fiscal 2025 [4] Industry Insights - The global rodenticides market was valued at $6.34 billion in 2024 and is anticipated to reach $8.64 billion by 2030, growing at a compound annual growth rate (CAGR) of 5.3% [7] - The rodenticides market is crucial for pest control, addressing challenges posed by rodent-borne diseases and crop damage [7] Product Innovations - Neogen launched the Neogen Molecular Detection Assay 2 – Quantitative Salmonella (MDA2QSAL96), which improves sensitivity and accuracy in pathogen testing [8] - In late 2024, Neogen introduced the Petrifilm Bacillus cereus Count Plate, providing a reliable testing method for food safety professionals [9]